Skip to main content
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1975 Jun;54(2):213–218. doi: 10.1111/j.1476-5381.1975.tb06931.x

The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions

JA Ribeiro, J Walker
PMCID: PMC1666647  PMID: 167894

Abstract

1 The effects of adenosine triphosphate (ATP) and adenosine diphosphate (ADP) were investigated on evoked end-plate potentials (e.p.ps) and on miniature end-plate potentials (min. e.p.ps) recorded from muscle fibres of the rat diaphragm and the frog sartorius.

2 ATP and ADP decreased the quantum content of the e.p.ps and the frequency of the min. e.p.ps. The maximum effects produced by the two substances were similar.

3 The potency of ATP was found to be similar to that of adenosine. In the presence of adenosine, in a concentration producing its maximum effect, the addition of ATP had no further effect. This is compatible with the idea that ATP acts in the same way as adenosine.

Full text

PDF
216

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Axelsson J., Holmberg B. The effects of extracellularly applied ATP and related compounds on electrical and mechanical activity of the smooth muscle taenia coli from the guinea-pig. Acta Physiol Scand. 1969 Jan-Feb;75(1):149–156. doi: 10.1111/j.1748-1716.1969.tb04366.x. [DOI] [PubMed] [Google Scholar]
  2. Burnstock G. Purinergic nerves. Pharmacol Rev. 1972 Sep;24(3):509–581. [PubMed] [Google Scholar]
  3. DEL CASTILLO J., KATZ B. Quantal components of the end-plate potential. J Physiol. 1954 Jun 28;124(3):560–573. doi: 10.1113/jphysiol.1954.sp005129. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. FATT P., KATZ B. An analysis of the end-plate potential recorded with an intracellular electrode. J Physiol. 1951 Nov 28;115(3):320–370. doi: 10.1113/jphysiol.1951.sp004675. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Ginsborg B. L., Hirst G. D., Maizels J. V., Walker J. Specificity of adenosine on transmitter output at the neuromuscular junction. Br J Pharmacol. 1973 Mar;47(3):637P–637P. [PMC free article] [PubMed] [Google Scholar]
  6. Ginsborg B. L., Hirst G. D. The effect of adenosine on the release of the transmitter from the phrenic nerve of the rat. J Physiol. 1972 Aug;224(3):629–645. doi: 10.1113/jphysiol.1972.sp009916. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. MARTIN A. R. A further study of the statistical composition on the end-plate potential. J Physiol. 1955 Oct 28;130(1):114–122. doi: 10.1113/jphysiol.1955.sp005397. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Martin A. R., Wickelgren W. O., Ber1anek R. Effects of iontophoretically applied drugs on spinal interneurons of the lamprey. J Physiol. 1970 May;207(3):653–665. doi: 10.1113/jphysiol.1970.sp009086. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Miyamota M. D., Breckenridge B. M. A cyclic adenosine monophosphate link in the catecholamine enhancement of transmitter release at the neuromuscular junction. J Gen Physiol. 1974 May;63(5):609–624. doi: 10.1085/jgp.63.5.609. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rasmussen H., Tenenhouse A. Cyclic adenosine monophosphate, CA++, and membranes. Proc Natl Acad Sci U S A. 1968 Apr;59(4):1364–1370. doi: 10.1073/pnas.59.4.1364. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Ribeiro J. A., Walker J. Action of adenosine triphosphate on endplate potentials recorded from muscle fibres of the rat-diaphragm and frog sartorius. Br J Pharmacol. 1973 Dec;49(4):724–725. doi: 10.1111/j.1476-5381.1973.tb08555.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sattin A., Rall T. W. The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices. Mol Pharmacol. 1970 Jan;6(1):13–23. [PubMed] [Google Scholar]
  13. WINBURY M. M., PAPIERSKI D. H., HEMMER M. L., HAMBOURGER W. E. Coronary dilator action of the adenine-ATP series. J Pharmacol Exp Ther. 1953 Nov;109(3):255–260. [PubMed] [Google Scholar]
  14. WOLF M. M., BERNE R. M. Coronary vasodilator properties of purine and pyrimidine derivatives. Circ Res. 1956 May;4(3):343–348. doi: 10.1161/01.res.4.3.343. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES